Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06359977

The Effect of Quantitative EEG Combined With Ultrasound and Sputum Volume on Predicting Weaning Failure

The Effect of Quantitative Electroencephalography Combined With Ultrasound and Sputum Volume on Predicting Weaning Failure in Neurocritical Patients

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Qingdao University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Neurocritical patients often face the need for removal of endotracheal tubes. However, despite following the extubation criteria for general critical ill patients, neurocritical patients still exhibit a higher rate of weaning failure, significantly higher than that of general critical ill patients. The extubation criteria for general critical patients emphasize the assessment of lung conditions. However, neurological critical patients often have less severe lung damage, but factors such as consciousness level and coughing ability may significantly influence extubation. Quantitative EEG serves as an objective tool to reflect consciousness level status, while bedside ultrasound can assess respiratory muscle function. Additionally, sputum volume may reflect the condition of lung condition. Therefore, we believe that combination of these three indicators can better predict the success of extubation for neurocritical patients.

Conditions

Interventions

TypeNameDescription
OTHERQuantitative EEG monitoring and beside ultrasound evaluationAfter successful spontaneous breathing trial, neurocritical patients undergo at least 2 hours of quantitative EEG monitoring before extubation. Additionally, bedside ultrasound assesses the thickness and variability of the diaphragm, intercostal muscles, rectus abdominis, transversus abdominis, and external oblique muscles. The sputum volume for the 24 hours prior to extubation is also recorded. Reintubation within 48 hours after extubation is defined as weaning failure.

Timeline

Start date
2024-04-15
Primary completion
2025-04-15
Completion
2025-05-15
First posted
2024-04-11
Last updated
2024-04-11

Source: ClinicalTrials.gov record NCT06359977. Inclusion in this directory is not an endorsement.